BDBM256913 US9493432, 37
SMILES: Fc1ccc2nc(N[C@H]3CCC[C@@H]3NC(=O)c3ccccc3Cl)sc2c1
InChI Key: InChIKey=WCSKESAUGFYFQM-GJZGRUSLSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orexin receptor type 2 (Homo sapiens (Human)) | BDBM256913![]() (US9493432, 37) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceuticals Company Limited US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US9493432 (2016) BindingDB Entry DOI: 10.7270/Q2FQ9VJT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin receptor type 1 (Homo sapiens (Human)) | BDBM256913![]() (US9493432, 37) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceuticals Company Limited US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US9493432 (2016) BindingDB Entry DOI: 10.7270/Q2FQ9VJT | |||||||||||
More data for this Ligand-Target Pair |